Multiple Ascending Dose Study of MHS552 in Adults Participants With Systemic Lupus Erythematosus (SLE)
Clinical trial NCT05203419 · TERMINATED
Trial details
- NCT number
- NCT05203419
- Sponsor
- Novartis Pharmaceuticals
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-03-15
- Primary completion
- 2023-06-04
- Enrollment
- 8
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.